about
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal SepsisAddressing Therapeutic Options for Ebola Virus Infection in Current and Future OutbreaksShedding light on filovirus infection with high-content imagingDevelopment of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred miceAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccinePanmicrobial Oligonucleotide Array for Diagnosis of Infectious DiseasesThe Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold[Haemostasis dysregulation in filovirus infections].Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentationExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialEbola virus - from neglected threat to global emergency state.[Overview of the Ebola vaccines in pre-clinical and clinical development].A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.Platelets support a protective immune response to LCMV by preventing splenic necrosis.The Baboon (Papio spp.) as a model of human Ebola virus infection.Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig modelDifferent potential of C-type lectin-mediated entry between Marburg virus strainsEvidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illnessSteric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primatesA single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challengeGlobal suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.Detection of cell-cell fusion mediated by Ebola virus glycoproteins.Ebola virus disease: an update for anesthesiologists and intensivists.Treatment of ebola virus disease.Shed GP of Ebola virus triggers immune activation and increased vascular permeabilityEbola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationThe emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts.A simian hemorrhagic fever virus isolate from persistently infected baboons efficiently induces hemorrhagic fever disease in Japanese macaquesEvasion of the interferon-mediated antiviral response by filoviruses.Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infectionRobust and sustained immune activation in human Ebola virus infection.Simian hemorrhagic fever virus: Recent advances.Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol ExposureInvestigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis.Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice
P2860
Q24568225-F1C332DE-CAA8-4B24-9CEF-ACE0726F90EBQ26783097-6063A026-3F05-4592-814C-1909CE116C0DQ26801423-8C74BA56-0D25-4A2F-B6A2-10F6593CA43BQ26863739-3F5661FE-58C5-4AA2-9786-AC7C59DE6722Q27024113-1686D60A-FE03-4A67-80DF-FFB65DEBB5BEQ27334697-288D479C-9187-41E0-809F-A319FD9B473DQ27489133-3AB6CB94-91F8-4AF8-9F0F-01C52ED09BB8Q27677595-F6B21E41-020C-4244-ABD6-9FB2EEEF48E3Q27691452-6048AC19-DE28-45DB-8687-28BAF72D1577Q28386164-742C28F2-45B2-4303-B66F-CF8BFE447716Q28551448-2647D95B-B1B1-4A6E-8BC2-7E6E2997FCF4Q30245153-8646A5D1-BCE6-46CB-B8C1-15922C48B9FFQ30245207-CB179F11-F1DC-49B2-95BC-6F6E93A5D661Q30279239-3E1E4A26-EABB-4F7A-A3EE-79486E333549Q33401102-543C993F-4A01-4692-8045-42975E8C5892Q33404644-431738C1-6468-43F3-9CEE-53CB21646937Q33558506-AD130699-E54B-484C-8270-6D21887D0A40Q33617999-CC49F589-BB76-41B4-BFFA-8B7431025308Q33826885-9218C56B-E981-4B39-8C6A-FDC86474E13DQ33952191-07F45021-B2AE-429B-8FA8-1A1FC2BB6C1FQ34115190-870CF42D-A50F-4DE8-A90F-0B5FF8439BFBQ34120895-3D9C01E6-33BB-40AA-82C9-E5A27A8FDEBEQ34434713-F2EC9C85-2AD5-47E2-8F81-A78913030A28Q34434866-5D0108EC-BD2B-427E-A41E-E143BA9B130FQ34435069-D0709EF6-DAE5-4D23-ACC6-FEE6405A908DQ34446478-21420B05-3777-47EB-BD62-51D029F6670DQ34460182-3904C1D1-F70A-454D-88FB-6FB23FFFDD3BQ34550148-33867345-ED43-4ADB-95EC-FBAB30F14234Q34648461-512D4C4D-81D7-4B6B-9B5A-3FF13BC5B46CQ34699060-DAD5245B-D424-4D6F-A33A-ADB69BDFC6D2Q35007037-0ED79490-1F62-49BE-AF27-33C9CEB6C8CCQ35260239-BDA70255-FB63-4749-BAFE-8C45F112CC0AQ35275167-0214A8AA-2048-4573-907C-7448F809C826Q35300007-0BE74029-B8B9-45DB-BCF3-FFB30494A8A4Q35300104-1321CDC7-73D7-47E2-8D30-452C60FEC7A4Q35485733-B114822D-274C-49CF-9BF8-D567C8E3FC79Q35666082-E891A2A8-5C12-452A-82BA-D8707FF3BCB9Q35790316-99E704EA-EB4D-4CF4-A6FB-17A7106AD0C5Q36010874-0D76FE6E-A58B-4EFD-B8B8-FE3E4B0D0B6BQ36043238-5E2DEEBE-C451-4846-81AC-15A73F622656
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathogenesis of filoviral haemorrhagic fevers.
@ast
Pathogenesis of filoviral haemorrhagic fevers.
@en
type
label
Pathogenesis of filoviral haemorrhagic fevers.
@ast
Pathogenesis of filoviral haemorrhagic fevers.
@en
prefLabel
Pathogenesis of filoviral haemorrhagic fevers.
@ast
Pathogenesis of filoviral haemorrhagic fevers.
@en
P1476
Pathogenesis of filoviral haemorrhagic fevers.
@en
P2093
P304
P356
10.1016/S1473-3099(04)01103-X
P577
2004-08-01T00:00:00Z